Geneos Wealth Management’s Invesco Zacks Mid-Cap ETF CZA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-296
Closed -$25K 2137
2022
Q2
$25K Hold
296
﹤0.01% 1582
2022
Q1
$28K Buy
296
+1
+0.3% +$92 ﹤0.01% 1629
2021
Q4
$28K Hold
295
﹤0.01% 1713
2021
Q3
$26K Hold
295
﹤0.01% 1780
2021
Q2
$26K Hold
295
﹤0.01% 1775
2021
Q1
$26K Hold
295
﹤0.01% 1935
2020
Q4
$24K Buy
295
+16
+6% +$1.16K ﹤0.01% 1789
2020
Q3
$18K Buy
279
+8
+3% +$522 ﹤0.01% 1694
2020
Q2
$16K Sell
271
-150
-36% -$8.71K ﹤0.01% 1717
2020
Q1
$22K Hold
421
﹤0.01% 1466
2019
Q4
$32K Hold
421
﹤0.01% 1471
2019
Q3
$30K Hold
421
﹤0.01% 1419
2019
Q2
$30K Sell
421
-100
-19% -$6.97K ﹤0.01% 1430
2019
Q1
$35K Hold
521
﹤0.01% 1316
2018
Q4
$30K Hold
521
﹤0.01% 1328
2018
Q3
$35K Sell
521
-150
-22% -$10.2K ﹤0.01% 1334
2018
Q2
$43K Buy
+671
New +$43.8K ﹤0.01% 1111

Other funds holding CZA

Geneos Wealth Management's CZA Position: Q3 2022 in Review

Geneos Wealth Management sold out of Invesco Zacks Mid-Cap ETF (CZA) in Q3 2022, closing a stake of 296 shares — an estimated $25K sold.

Geneos Wealth Management first reported a position in CZA in Q2 2018 and held it in 17 quarters. The position peaked at $43K in Q2 2018. 56 funds tracked by Wall St. Rank hold CZA as of Q3 2022.

  • Geneos Wealth Management reported no remaining Invesco Zacks Mid-Cap ETF position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 296 Invesco Zacks Mid-Cap ETF shares in Q3 2022, an estimated $25K.
  • Geneos Wealth Management first reported a position in Invesco Zacks Mid-Cap ETF in Q2 2018 and held it in 17 quarters.
  • Geneos Wealth Management's Invesco Zacks Mid-Cap ETF position peaked at $43K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held Invesco Zacks Mid-Cap ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.